Cosmetic surgery warning update following rare cases of medical condition

Cosmetic surgery warning update following rare cases of medical condition The MHRA is strengthening safety warnings for all the products In a new update issued today (July 15), the Medicines and Healthcare products Regulatory Agency (MHRA) confirmed it is stepping up its safety warnings for all products containing botulinum toxin type A due to rare reports of botulism linked to these products. While this toxin is commonly used in both medical and cosmetic procedures, it can sometimes spread beyond the intended area. This spread can lead to botulism, which is a serious and potentially fatal illness. Botulinum toxin type A is a prescription-only medicine (POM) in the UK. It is authorised to treat a number of conditions, including muscle spasms, hyperhidrosis (excess sweating from armpits), and an overactive bladder. To raise more awareness about iatrogenic botulism—botulism that occurs due to medical treatment—the MHRA has worked with manufacturers to improve product labels and patient information leaflets. Botulism is a rare but life-threatening condition that attacks the nervous system. Common symptoms include muscle weakness, breathing difficulties, slurred speech, or difficulty swallowing. If patients experience these symptoms within four weeks after treatment, they are strongly encouraged to seek immediate medical attention. Dr Alison Cave, MHRA Chief Safety Officer, said: "Botulinum toxin products are effective for a number of different medical and cosmetic purposes when used correctly. However, these strengthened warnings are an important reminder that, in rare cases, serious side effects can occur. “It is vital that healthcare professionals and patients are aware of the symptoms of botulism and act quickly if they arise as this is a medical emergency. We also strongly urge the public to avoid unlicensed products and seek treatment only from appropriately qualified practitioners. The MHRA continuously monitors the safety of these medicines, including side effects and emerging evidence." Dr Martin Bewley, Consultant in Health Protection from UKHSA, said: "While botulism is a rare infection, it can be serious. There are effective treatments available and we recommend seeking immediate medical advice if you have had a recent treatment and are having symptoms such as difficulty swallowing. "Contact NHS 111 (or local equivalent in Northern Ireland) for further advice and seek immediate medical attention. It is important to get checked out so you can have peace of mind and treatment if needed. Given the risks, it is also important to go to a licensed practitioner." If you're planning to get botulinum toxin for a cosmetic treatment, the NHS provides helpful information to help you select a suitable prescriber. The risk of adverse reactions may be higher in certain circumstances, including; - in patients with certain underlying conditions, such as neurological disorders, a history of dysphagia (difficult swallowing) or a history of aspiration (breathing in a foreign material) - where high doses are used - where products are used outside of their licensed indications or into an unapproved site. The MHRA is highlighting significant risks associated with unlicensed and counterfeit botulinum toxin products, which fail to meet UK safety and quality standards. Following a rise in hospital admissions, the MHRA's Criminal Enforcement Unit is actively investigating the use of these illegal products. To stay safe, patients should: - Ensure their practitioner is properly qualified. - Confirm that any product used is officially authorised in the UK. - Report any suspected side effects through the MHRA’s Yellow Card scheme.